The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or original human data
PubMed 29951057 · doi:10.3389/fimmu.2018.01302
What was done
This narrative review synthesized literature on the clinical significance and biological roles of C-reactive protein (CRP) and its distinct structural conformations (native pentameric CRP and monomeric CRP) across chronic inflammatory and neurodegenerative conditions, including cardiovascular disease, type 2 diabetes mellitus, age-related macular degeneration, hemorrhagic stroke, Alzheimer's disease, and Parkinson's disease.
What was found
The abstract reports no numerical findings or effect sizes. It qualitatively describes that CRP is associated with chronic inflammation in prospective studies and that distinct conformational forms (native pentameric versus monomeric CRP) exhibit different receptor- and lipid raft-binding properties that may influence disease pathogenesis.
Why it matters
The review outlines how distinct structural forms of CRP might serve functional pathogenic roles in chronic and neurodegenerative disorders rather than acting merely as passive markers of acute inflammation.
Limits
The abstract reports no empirical data or quantitative metrics. As a narrative review rather than a systematic review, it lacks formal study selection criteria, risk of bias assessments, and aggregate sample size reporting.
Cited by
- supports C-reactive protein (CRP) is synthesized by hepatocytes in the liver.